BTIG Upgrades DexCom (DXCM) to Buy
BTIG upgraded DexCom (NASDAQ: DXCM) from Neutral to Buy with a price target of $92. Analyst Sean Lavin sees an ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
